IL-6 Antikörper

Produktnummer ABIN2191748

Produktdetails anti-IL-6 Antikörper

Target: IL-6 (IL6) (Interleukin 6 (IL6))

Reaktivität: Maus

Wirt: Ratte

Klonalität: Monoklonal

Konjugat: Dieser IL-6 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Neutralization (Neut), Immunoassay (IA), Detection (D)

Sterilität: 0.2 μm filtered

Klon: MP5-32C11

Anwendungsinformationen

Applikationshinweise: For Western blotting dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:10. For neutralisation of biological activity dilutions have to be made according to the amount of IL-6 to be inactivated.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: PBS, containing 0.1 % bovine serum albumin.

Handhabung: Repeated freeze and thaw cycles will cause loss of activity. Under recommended storage conditions, product is stable for one year.

Lagerung: 4 °C

Informationen zur Lagerung: Lyophilized product should be stored at 4 °C Store stock solution in aliquots at -20 °C Repeated freeze and thaw cycles will cause loss of activity. Under recommended storage conditions, product is stable for one year.

Haltbarkeit: 12 months

Referenzen für anti-IL-6 Antikörper (ABIN2191748)

Hirano: "Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias." in: International journal of cell cloning, Vol. 9, Issue 3, pp. 166-84, (1991) (PubMed).

Hooghe-Peters, Velkeniers, Vanhaelst, Hooghe: "Interleukin-1, interleukin-6: messengers in the neuroendocrine immune system?" in: Pathology, research and practice, Vol. 187, Issue 5, pp. 622-5, (1991) (PubMed).

Takatsuki, Okano, Suzuki, Chieda, Takahara, Hirano, Kishimoto, Hamuro, Akiyama: "Human recombinant IL-6/B cell stimulatory factor 2 augments murine antigen-specific antibody responses in vitro and in vivo." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 141, Issue 9, pp. 3072-7, (1988) (PubMed).

McKenzie: "Alloantigen presentation by B cells. Requirement for IL-1 and IL-6." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 141, Issue 9, pp. 2907-11, (1988) (PubMed).

Details zu IL-6

Target: IL-6 (IL6) (Interleukin 6 (IL6))

Andere Bezeichnung: Interleukin 6 (IL6 Produkte)

Synonyme: BSF2 antikoerper, HGF antikoerper, HSF antikoerper, IFNB2 antikoerper, IL-6 antikoerper, Il-6 antikoerper, ILg6 antikoerper, Ifnb2 antikoerper, il6 antikoerper, CHIL-6 antikoerper, interleukin 6 antikoerper, interleukin-6 antikoerper, IL6 antikoerper, Il6 antikoerper, il-6 antikoerper, IL-6 antikoerper

Hintergrund: The antibody neutralizes mouse interleukin 6 (IL-6). It does not cross-react with LPS (the component of the bacterial cell wall which is considered responsible for the toxicity of gram-negative bacteria) and TNF- alpha nor does it block human or rat IL-6 in proliferation assays using the KD83 cell line. MP5-32C11 inhibits mouse IL-6-induced proliferation of the NFS60 myelomonocytic cell line and KD83 plasmacytoma. IL-6 is a pluripotent 20-22 kDa cytokine which plays a role in the pathophysiology of severe infection and regulates the immune response, acute phase reaction and haematopoiesis. IL-6 plays a critical role in B- cell differentiation to plasma cells and is a potent growth factor for plasmacytoma and myeloma. Continuous IL-6 gene expression makes an essential contribution to a multistep oncogenesis of plasma cell neoplasia. IL-6 is a very useful culture supplement for the generation of a high number of antibody- producing hybridomas.

Pathways: TLR Signalweg, Hormone Transport, Negative Regulation of Hormone Secretion, Myometrial Relaxation and Contraction, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Regulation of Carbohydrate Metabolic Process, Autophagie, Cell RedoxHomeostasis, Cancer Immune Checkpoints, Inflammasome